Want to create an interactive transcript for this episode?
Podcast: Tech Can't Save Us
Episode: Transforming Alzheimer's disease diagnosis through blood tests with Dr. Joel Braunstein, CEO and Co-founder of C2N Diagnostics
Description:
This week on Tech Can’t Save Us, host Paul David is joined by Dr. Joel Braunstein, co-founder, CEO, and president of C2N Diagnostics, a pioneering biotech company transforming the way we diagnose Alzheimer’s disease.They explore how C2N is advancing blood-based diagnostic tools, most notably the Precivity AD test that delivers accuracy comparable to PET scans and spinal taps, but in a simpler, less invasive format. Joel shares how these innovations are reducing misdiagnosis rates, empowering clinicians, and providing families with clarity during some of their most difficult moments.Joel reflects on h...